Related Stories

Learn About Effective Medications For Treating Opioid Addiction - 04/30/2019

If you are interested in learning about effective medications for fighting opioid-use disorder, be sure to attend the upcoming Texas Grand Rounds online webinar this week. The webinar, presented by the Opioid Response Network, will discuss the effectiveness of Naltrexone and Buprenorphine-Naloxone in treating patients with opioid-use disorder.


An Easy Way To Curb Substance Abuse - 04/26/2019

Are you looking for more ways to help stop substance abuse in your community? You can start by encouraging your patients to participate in the Drug Enforcement Administration’s National Prescription Drug Take Back Day.


Federal Bill Would Limit Opioid Scrips for Acute Pain - 04/22/2019

The proposed three-day limit on opioid prescriptions for acute pain would be one of the more impactful provisions for pain doctors and their patients. Exceptions would include prescriptions for chronic pain, cancer care, hospice or end-of-life care, and pain treatment that’s part of palliative care.


TMA Pushing To Delay PMP Mandate, Buy Time for Integration With EHRs - 04/09/2019

Starting Sept. 1, physicians will be required to check the PMP before issuing any prescription for opioids, barbiturates, benzodiazepines, or carisoprodol, a mandate the Texas Legislature passed during the 2017 session. As this year’s session of the legislature enters its back stretch, TMA is hoping to persuade lawmakers to delay that mandate until March 2020 to allow for a widespread rollout of PMP-EHR integration.


Google Your Way To Disposing Of Unused Drugs? - 03/21/2019

If you’re looking for a way to help your patients put a dent in the nation’s opioid epidemic, look no further than Google Maps.  Google Maps recently added a search feature that will make it easier for your patients to dispose of unwanted and unused medications.  


Keep Your Patients and Practice Safe from Opioid Prescription Fraud - 03/19/2019

If you prescribe opioids, it’s important to protect your practice and your patients from fraud and substance-use disorder. One way to ensure that patients accurately follow your prescription is to have them sign an informed consent and opioid treatment agreement.


Pharmacy Board Nixes Proposal That Could’ve Broadened Pharmacists’ Scope - 03/14/2019

Medicine’s objections were strong, and the state’s draft rules allowing pharmacists to perform medication therapy management services aren’t going to make it after all.


Prevention of Opioid Abuse Through Education - 03/13/2019

HB 405 was written to require collaborative efforts and involve many stakeholders who are involved in the health and well-being of mothers and infants across our state. This is the best way to ensure that as many women as possible hear about NAS and its harmful outcomes. Creating more awareness of what causes NAS and potential impacts of the condition will only help our state become a better place for all mothers and babies. HB 405 would help bring needed attention and resources to help educate our state on NAS.


New Prescription Forms Taking More Than Eight Weeks To Deliver, State Says - 03/11/2019

Update March 11: New official prescription forms for certain controlled substances could take longer than two months to receive, state health officials say.  


Bypassing the Middle Man: Should Texas Allow Physician Dispensing? - 02/11/2019

The Texas Medical Association supports allowing physicians to dispense out of their offices, and TMA and the Texas Academy of Family Physicians (TAFP) are supporting business groups and other leaders as they mount a legislative effort to bring the practice to Texas. Proponents are wielding data that illustrates potential benefits like reduced medication costs and increased patient adherence to their drug regimens.


TMA Weighs In on Opioid-Antagonist Prescriptions - 02/11/2019

The Texas Medical Association continues to track key regulatory changes that could affect your practice, and recently submitted comments on the Texas Medical Board’s proposed rule for the use of opioid antagonists.


Is the PMP Working for You? - 01/16/2019

The Texas Medical Association, in collaboration with the Center for Health Communication at The University of Texas at Austin, invites you to share your expertise on using the Prescription Monitoring Program to help care for your patients.


New Prescription Forms Taking Months to Deliver - 12/20/2018

If you haven’t already ordered new prescription forms for certain controlled substances, you should do so soon in order to stay compliant with new state regulations that will take effect next year. Because of the volume of orders, the new forms are currently taking about two months to be delivered.


Opioid Overreach? State, Retail Pharmacy Policies Prompt Scope-of-Practice Concerns - 12/07/2018

Worries over what’s been termed a national opioid epidemic is leading to new state and corporate pharmacy policies that could blur the line between the practice of pharmacy and the practice of medicine.


Physicians Warn of Overreach in New Pharmacy Prescription Rules - 12/05/2018

Physicians are questioning whether some Texas pharmacists are overstepping bounds by using a new rule to second-guess whether a doctor’s prescription is appropriate.


Effects of Opioids and Nonsteroidal Anti-Inflammatory Drugs on Chronic Low Back Pain and Related Measures: Results from the PRECISION Pain Research Registry - 11/29/2018

Measuring treatments used by 202 patients with chronic low back pain in the PRECISION Pain Research Registry, this study determined the associations of opioid and nonsteroidal anti-inflammatory drug (NSAID) therapy with clinical status. More than one-fourth of patients did not use nonpharmacologic treatments for low back pain. Patients age 50-59 and 60-79 years old were more likely to use opioids than younger patients. Patients using opioids reported greater pain and back-related disability than did patients using NSAIDs. Patients concurrently using opioids and NSAIDs reported greater back-related disability and poorer quality of life than did patients using no or other pharmacologic therapy. No significant associations between pharmacologic therapy and clinical status remained after controlling for potential confounders. Neither opioids nor opioids combined with NSAIDs were more effective than just NSAIDs. Greater use of nonpharmacologic therapies and better second-line, nonopioid ph...


Cannabidiol Takes a Big Step Toward Respectability - 11/29/2018

In September, the DEA issued an order listing all drugs approved by the U.S. Food and Drug Administration that contain cannabidiol but no more than 0.1 percent of the chief psychoactive agent in cannabis as Schedule V drugs — those with the least potential for abuse. So far, Epidiolex is the only medication that fits that description.


New Prescription Form Requirements Delayed - 11/26/2018

The Texas State Board of Pharmacy has pushed back the date for when new prescription forms for certain controlled substances will be required.


Too Big a Step? Medicine Urges CMS to Reverse New Step Therapy Policy - 11/02/2018

Medicine urges CMS to reverse new policy allowing “fail-first” drug programs known as step therapy.


Are You Ready for Changes to Opioid Prescribing in Texas? - 10/30/2018

Beginning Sept. 1, all prescribers will be required to set up an account with the state’s prescription monitoring program, known as PMP Aware. The Texas State Board of Pharmacy will also begin issuing new official prescription forms that include advanced security features designed to help deter fraud.


New FDA-Approved Flu Drug Has Roots in Texas - 10/25/2018

The science behind what makes a new flu drug work has roots right here in Texas, particularly The University of Texas at Austin (UT).


Help Prevent Opioid Abuse With Drug Take Back Day - 10/22/2018

Twice each year, the DEA puts on Drug Take Back Day to provide a safe, convenient, and anonymous way for people to dispose of their unused prescription drugs. The next one is scheduled for Saturday, Oct. 27 at locations throughout the state. TMA supports such community programs as part of its policy on addressing prescription drug abuse and overdose.


Texas Gets $46 Million to Fight Opioid Abuse - 10/12/2018

The Substance Abuse and Mental Health Services Administration recently awarded the Texas Health and Human Services Commission $46.2 million to expand treatment options and to increase access to medication-assisted treatment.


Update: Glitches With State's Schedule II Prescription Forms Fixed - 09/21/2018

Some physicians have not been able to order new prescription forms for certain controlled substances because of problems with the state’s IT system, and the texas.gov website.


Why Marijuana Will Not Fix the Opioid Epidemic - 09/19/2018

There is sufficient and expanding evidence demonstrating that medical marijuana use will not curb the opioid epidemic. There is further evidence that marijuana is a companion drug rather than substitution drug and that marijuana use may be contributing to the opioid epidemic rather than improving it.